Shareholders meeting

26 August 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Notice of the 8th Annual General Meeting (AGM) and Integrated Annual Report 2025-26 With reference to the above subject, pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Notice convening the 8th AGM of the Members of the Company and the Integrated Annual Report for the financial year 2025-26 which is simultaneously circulated to the shareholders through electronic mode. The Notice of 8th AGM and Integrated Annual Report 2026 are available on the Company’s website at: https://www.cohance.com/wp-content/uploads/2026/08/Cohance_Integrated-Annual-Report_2026.pdf The schedule of the AGM is set out below: Event Event details Date and time of AGM Thursday, 17 September 2026 at 04:00 p.m. (IST) Mode Video Conference (VC)/ Other Audio-Visual Means (OAVM) Cut-off date for e-voting Thursday, 10 September 2026 E-voting start date and time Monday, 14 September 2026 at 9.00 a.m. IST E-voting end date and time Wednesday, 16 September 2026 at 5.00 p.m. IST Kindly take the above on record. Thanking You. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary & Compliance Officer Encl: a/a Notice of 8th Annual General Meeting NOTICE is hereby given that the Eighth Annual General Item No. 2 – Adoption of consolidated financial statements Meeting of the Members of Cohance Lifesciences Limited To receive, consider and adopt the audited consolidated (formerly, Suven Pharmaceuticals Limited) will be held on financial statements of the Company for the year ended Thursday, September 17, 2026 at 4:00 PM (IST) through Video March 31, 2026 together with the report of the Auditors thereon. Conferencing (“VC”) / Other Audio Visual Means (“OAVM”), to transact the following businesses: “RESOLVED THAT the audited consolidated financial statements of the Company for the financial year ended ORDINARY BUSINESS March 31, 2026, together with the report of the Auditors Item No. 1 – Adoption of standalone financial statements thereon, be and are hereby received, considered and adopted.” To receive, consider and adopt the audited standalone financial Item No. 3 – Reappointment of Ms. Shweta Jalan, Director statements of the Company for the year ended March 31, 2026 liable to retire by rotation together with the reports of the Board of Directors and the To appoint a director in place of Ms. Shweta Jalan (DIN: Auditors thereon. 00291675), who retires by rotation, and being eligible, offers “RESOLVED THAT the audited standalone financial statements herself for re-appointment. of the Company for the financial year ended March 31, 2026, “RESOLVED THAT pursuant to the provisions of Section 152 together with the reports of the Board of Directors and of the of the Companies Act, 2013, Ms. Shweta Jalan (DIN: 00291675), Auditors thereon, be and are hereby received, considered Director who retires by rotation at this meeting and being and adopted.” eligible, offers herself for reappointment, be and is hereby appointed as a Director, liable to retire by rotation.” By order of the Board of Directors For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Date: August 5, 2026 Company Secretary Place: Mumbai Membership No. F8555 Registered Office: 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC, Mumbai- 400093, Maharashtra, India Corporate Office: 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad - 500081 Telangana, India CIN: L24299MH2018PLC422236 Email: investorservices@cohance.com Website: https://www.cohance.com/ Cohance Lifesciences Limited Notice NOTES FOR MEMBERS’ ATTENTION: 6. The facility for attending the AGM virtually will be made available for 1,000 members on first come first served 1. Since all the businesses proposed to be transacted at basis. This will not include Members with 2% or more the Annual General Meeting are ordinary businesses, shareholding, Promoters, institutional investors, Directors, no Explanatory Statement pursuant to Section 102 of Key Managerial Personnel, the Chairpersons of the Audit the Companies Act, 2013 is annexed to this Notice. Committee, Nomination and Remuneration Committee Further, the relevant details, with respect to the Director and Stakeholders’ Relationship Committee, Auditors, etc. seeking re-appointment at this AGM, pursuant to who are allowed to attend the AGM without restriction on Regulation 36(3) of the SEBI (Listing Obligations and account of first come first served basis. Disclosure Requirements), Regulations, 2015 (“SEBI Listing Regulations”) and Secretarial Standard-2 on General 7. The Members can join the AGM in the VC/OAVM mode 15 Meetings issued by the Institute of Company Secretaries minutes before the scheduled time of the commencement of India are annexed to this notice. of the AGM by following the procedure mentioned in this Notice. The Insta Poll facility shall remain available during 2. The Ministry of Corporate Affairs, Government of India the AGM and for 15 minutes after conclusion of the AGM. (“MCA”), and the Securities and Exchange Board of India (“SEBI”), allowed companies to conduct Annual General 8. Corporate members whose authorized representatives are Meeting (“AGM”) through video conference (“VC”)/ other intending to attend the meeting are requested to send audio-visual means (“OAVM”), without the physical a certified copy of the Board resolution authorizing such presence of Members at a common venue. Pursuant to representative to attend the 8th AGM through VC/ OAVM General Circular Nos. 14/2020 dated April 8, 2020, 17/2020 and cast their votes through e-voting. Such documents dated April 13, 2020, 20/2020 dated May 5, 2022, 09/2024 may be emailed to prenukaacs@gmail.com, with a copy dated September 19, 2024, 03 / 2025 dated September 22, marked to investorservices@cohance.com. 2025 and other circulars issued by the Ministry of Corporate Affairs (‘MCA’) and the SEBI Circular Nos. SEBI/HO/CFD/ 9. Institutional shareholders (i.e. other than individuals, CMD1/CIR/P/2020/79 dated May 12, 2020 and SEBI/ HUF, NRI etc.) are required to send scanned copy (PDF/ HO/CFD/CFD-PoD-2/P/CIR/2024/133 dated October 3, JPG Format) of the relevant Board Resolution/ Authority 2024, respectively (collectively referred to as ‘Circulars’), letter, etc. with attested specimen signature of the duly companies are permitted to hold the AGM through VC/ authorized signatory(ies) who are authorized to vote, to OAVM, without the physical presence of the members at a the Scrutinizer by e-mail at prenukaacs@gmail.com, with common venue. Accordingly, the 8th AGM of the Company a copy marked to investorservices@cohance.com. will be convened through VC/ OAVM in compliance with the provisions of the Act and Rules made thereunder, the 10. Members attending the 8th AGM through VC/ OAVM shall SEBI Listing Regulations read with the aforesaid Circulars. be counted for the purpose of reckoning the quorum The deemed venue for the 8th AGM shall be the Registered under Section 103 of the Act. Office of the Company. 11. In case of joint holders attending the Meeting, only such 3. In line with the Circulars, the Company is providing VC/ joint holder who is higher in the order of names will be OAVM facility to its members to attend the 8th AGM. entitled to vote at the AGM. For this purpose, the Company has entered into an 12. The statutory registers including Register of Directors agreement with KFin Technologies Limited (“KFintech”), and Key Managerial Personnel and their shareholding, as the authorized agency for facilitating voting th [Showing first 8,000 characters — download PDF for full document]